Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California

Venice Servellita, Mary-Kate Morris, Alicia Sotomayor-Gonzalez, Amelia S. Gliwa, Erika Torres, Noah Brazer, Alicia Zhou, Katherine T. Hernandez, Madeline Sankaran, Baolin Wang, Daniel Wong, Candace Wang, Yueyuan Zhang, Kevin R Reyes, Dustin Glasner, Xianding Deng, Jessica Streithorst, Steve Miller, Edwin Frias, John Hackett Jr., Carl Hanson, Debra Wadford, Susan Philip, Scott Topper, Darpun Sachdev, View ORCID ProfileCharles Y. Chiu
doi: https://doi.org/10.1101/2021.08.19.21262139
Venice Servellita
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary-Kate Morris
3Viral and Rickettsial Disease Laboratory, California Department of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alicia Sotomayor-Gonzalez
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amelia S. Gliwa
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erika Torres
4Color Genomics, Inc., San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noah Brazer
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alicia Zhou
4Color Genomics, Inc., San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine T. Hernandez
5San Francisco Department of Public Health, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madeline Sankaran
5San Francisco Department of Public Health, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baolin Wang
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Wong
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Candace Wang
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yueyuan Zhang
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin R Reyes
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dustin Glasner
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xianding Deng
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Streithorst
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Miller
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edwin Frias
6Abbott Laboratories, Abbott Park, Illinois, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Hackett Jr.
6Abbott Laboratories, Abbott Park, Illinois, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl Hanson
3Viral and Rickettsial Disease Laboratory, California Department of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debra Wadford
3Viral and Rickettsial Disease Laboratory, California Department of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Philip
5San Francisco Department of Public Health, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Topper
4Color Genomics, Inc., San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darpun Sachdev
5San Francisco Department of Public Health, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Y. Chiu
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
7Department of Medicine, University of California San Francisco, California, USA
8Innovative Genomics Institute, University of California Berkeley, Berkeley, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Charles Y. Chiu
  • For correspondence: charles.chiu@ucsf.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

Data Availability Assembled SARS-CoV-2 genomes in this study were uploaded to GISAID (accession numbers in Supplementary Table S2) and can be visualized in NextStrain. Viral genomes were also submitted to the National Center for Biotechnology Information (NCBI) GenBank database (accession numbers pending). Raw sequence data were submitted to the Sequence Read Archive (SRA) database. (BioProject accession number PRJNA722044 and umbrella BioProject accession number PRJNA171119). Code Availability FASTA files and scripting code for data analyses are available in a Zenodo data repository (https://doi.org/10.5281/zenodo.5207242).

https://doi.org/10.5281/zenodo.5207242

Back to top
PreviousNext
Posted August 25, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Venice Servellita, Mary-Kate Morris, Alicia Sotomayor-Gonzalez, Amelia S. Gliwa, Erika Torres, Noah Brazer, Alicia Zhou, Katherine T. Hernandez, Madeline Sankaran, Baolin Wang, Daniel Wong, Candace Wang, Yueyuan Zhang, Kevin R Reyes, Dustin Glasner, Xianding Deng, Jessica Streithorst, Steve Miller, Edwin Frias, John Hackett Jr., Carl Hanson, Debra Wadford, Susan Philip, Scott Topper, Darpun Sachdev, Charles Y. Chiu
medRxiv 2021.08.19.21262139; doi: https://doi.org/10.1101/2021.08.19.21262139
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Venice Servellita, Mary-Kate Morris, Alicia Sotomayor-Gonzalez, Amelia S. Gliwa, Erika Torres, Noah Brazer, Alicia Zhou, Katherine T. Hernandez, Madeline Sankaran, Baolin Wang, Daniel Wong, Candace Wang, Yueyuan Zhang, Kevin R Reyes, Dustin Glasner, Xianding Deng, Jessica Streithorst, Steve Miller, Edwin Frias, John Hackett Jr., Carl Hanson, Debra Wadford, Susan Philip, Scott Topper, Darpun Sachdev, Charles Y. Chiu
medRxiv 2021.08.19.21262139; doi: https://doi.org/10.1101/2021.08.19.21262139

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (506)
  • Anesthesia (110)
  • Cardiovascular Medicine (1245)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (534)
  • Epidemiology (10032)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2464)
  • Geriatric Medicine (238)
  • Health Economics (480)
  • Health Informatics (1647)
  • Health Policy (754)
  • Health Systems and Quality Improvement (637)
  • Hematology (250)
  • HIV/AIDS (536)
  • Infectious Diseases (except HIV/AIDS) (11872)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (253)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2290)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1249)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (734)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4843)
  • Radiology and Imaging (843)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (652)
  • Rheumatology (286)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (227)
  • Surgery (269)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)